×
-0.0991150442477877 -0.0991150442477877 -0.0991150442477877 -0.0991150442477877 -0.0477876106194691 -0.0442477876106195 -0.0115044247787611 -0.0584070796460177
Stockreport

Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development

ARCTURUS THERAPEUTICS LTD (ARCT)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF Dr. Pad Chivukula Resigns as Chief Scientific Officer and Chief Operating Officer SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that Dr. Christine Esau, Senior Director of Translational Research, has been appointed as Vice President of Research and Development, effective immediately. Concurrently, Dr. Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the Company. “Christine brings more than a decade of experience in microRNA drug discovery, development and commercialization,” said Mark R. Herbert, Interim President. “Given her experience with Arcturus over the past several years, we are confident that in this new role, Christine will immediately contribute to the progress we are making in developing innovative RNA medicines with the potential to transform the lives of patients with serious diseases. We are please [Read more]

IMPACT SNAPSHOT EVENT TIME: ARCT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS